Phase II study of gemcitabine and trastuzumab therapy in patients with HER2 [human epidermal growth factor receptor-2] overexpressing metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2007
At a glance
- Drugs Gemcitabine; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 Sep 2007 Status changed from in progress to completed.
- 27 Jul 2006 Status change
- 28 Oct 2005 New trial record.